中国动脉硬化杂志2024，Vol.32Issue(7)：553-557,5.DOI:10.20039/j.cnki.1007-3949.2024.07.001
《代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)》解读
Interpretation and practical application of guidelines for the prevention and treatment of metabolic dysfunction-associated(non-alcoholic)fatty liver disease(Version 2024)
摘要
Abstract
With the prevalence of obesity and metabolic syndrome,non-alcoholic fatty liver disease(NAFLD)has replaced chronic hepatitis B as the leading chronic liver disease in China.In recent years,continuous exploration of the epidemiology and natural history of this disease,proposals for renaming,rapid advancements in diagnostic techniques,and continuous updates in treatment methods have propelled significant progress in the related diagnostic and therapeutic fields.Recently,experts in the Chinese Society of Hepatology revised the"Guidelines for the Prevention and Treatment of Non-Al-coholic Fatty Liver Disease(2018 Updated Version)"and published the"Guidelines for the Prevention and Treatment of Metabolic Dysfunction-associated(Non-alcoholic)Fatty Liver Disease(Version 2024)".The updated guideline provides guiding recommendations on important clinical issues such as renaming and sorting,screening and monitoring,diagnosis and assessment,treatment,and follow-up for this disease.This article aims to interpret the key updates in this guideline to help clinical practitioners gain a more comprehensive understanding and apply them to guide clinical practice.关键词
代谢相关脂肪性肝病/非酒精性脂肪性肝病/指南Key words
metabolic dysfunction-associated fatty liver disease/non-alcoholic fatty liver disease/guideline分类
医药卫生引用本文复制引用
曾静,范建高..《代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)》解读[J].中国动脉硬化杂志,2024,32(7):553-557,5.基金项目
国家自然科学基金项目(82170593、82100605) （82170593、82100605）
国家重点研发计划项目(2021YFC2700802) （2021YFC2700802）
上海交通大学交大之星计划项目(YG2021QN54) （YG2021QN54）
